P. Zhou et al., HUMAN MONOCYTES PRODUCE MONOCYTE CHEMOATTRACTANT PROTEIN-1 (MCP-1) INRESPONSE TO A SYNTHETIC PEPTIDE DERIVED FROM C-REACTIVE PROTEIN, Clinical immunology and immunopathology, 74(1), 1995, pp. 84-88
We reported previously that a synthetic peptide (RS-83277) derived fro
m human C-reactive protein (CRP) augmented human monocyte/macrophage t
umoricidal activity and cytokine production. RS-83287, a synthetic pep
tide derived from a different CRP site, was ineffective. Because chemo
attractant properties have been attributed to some CRP-derived peptide
s, we hypothesized that RS-83277, in addition to activating effects, m
ight promote human monocyte chemotaxis. Results indicated that neither
CRP peptide RS-83277 nor RS-83287 was, itself, a chemoattractant. RS-
83277, but not RS-83287, however, elicited time-dependent production o
f monocyte chemoattractant activity in conditioned media (CM) of cultu
red human mononuclear leukocytes and purified, adherent monocytes (RIG
). CM from nonadherent MO contained no activity, indicating that adher
ence was required for monocyte response. Monocyte chemoattractant acti
vity was dose-dependent and was removed by treatment with immobilized
antibody to human monocyte chemoattractant protein 1 (MCP-1) but not b
y irrelevant IgG. These results indicate that a specific peptide segme
nt of CRP acts upon human adherent monocytes to promote production of
the autocrine chemotactic and activating factor MCP-1. Data suggest th
at degraded CRP represents a complex source of biologically active pep
tides which, among other effects, may amplify monocyte recruitment to
sites of injury, (C) 1995 Academic Press, Inc.